Pompili, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 10.483
EU - Europa 9.916
AS - Asia 8.640
SA - Sud America 1.870
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 19
Totale 31.152
Nazione #
US - Stati Uniti d'America 10.192
SG - Singapore 4.121
DE - Germania 3.529
CN - Cina 2.386
SE - Svezia 1.724
BR - Brasile 1.515
IT - Italia 1.086
UA - Ucraina 733
FR - Francia 551
IE - Irlanda 511
GB - Regno Unito 461
VN - Vietnam 424
FI - Finlandia 349
ID - Indonesia 336
IN - India 287
RU - Federazione Russa 255
PL - Polonia 233
TR - Turchia 230
AR - Argentina 145
CA - Canada 135
HK - Hong Kong 124
BD - Bangladesh 115
JP - Giappone 106
IQ - Iraq 89
MX - Messico 87
NL - Olanda 78
BE - Belgio 70
KR - Corea 65
AT - Austria 63
ES - Italia 61
EC - Ecuador 58
ZA - Sudafrica 52
IR - Iran 41
SA - Arabia Saudita 40
CI - Costa d'Avorio 35
CZ - Repubblica Ceca 35
PK - Pakistan 34
VE - Venezuela 29
IL - Israele 28
CH - Svizzera 27
LT - Lituania 27
AE - Emirati Arabi Uniti 26
CO - Colombia 26
MA - Marocco 26
PE - Perù 26
PH - Filippine 26
PY - Paraguay 26
EG - Egitto 22
RO - Romania 22
EU - Europa 21
UZ - Uzbekistan 20
KE - Kenya 18
JO - Giordania 17
UY - Uruguay 17
AU - Australia 16
CL - Cile 16
KG - Kirghizistan 15
PT - Portogallo 14
NP - Nepal 13
AL - Albania 12
AZ - Azerbaigian 12
GR - Grecia 12
PA - Panama 12
TW - Taiwan 12
KZ - Kazakistan 11
HU - Ungheria 10
BG - Bulgaria 9
BO - Bolivia 9
DZ - Algeria 9
CR - Costa Rica 8
TT - Trinidad e Tobago 8
BZ - Belize 7
HN - Honduras 7
NI - Nicaragua 7
BH - Bahrain 6
DK - Danimarca 6
GE - Georgia 6
JM - Giamaica 6
LK - Sri Lanka 6
MD - Moldavia 6
MY - Malesia 6
OM - Oman 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
TN - Tunisia 5
TZ - Tanzania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CG - Congo 4
CY - Cipro 4
KW - Kuwait 4
LV - Lettonia 4
NO - Norvegia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
KH - Cambogia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
Totale 31.098
Città #
Singapore 1.985
Chandler 1.553
Ashburn 1.096
Dublin 504
New York 445
Dallas 440
Beijing 422
Jacksonville 421
San Mateo 328
Los Angeles 311
Nanjing 307
Jakarta 300
Hefei 267
Ann Arbor 234
Boston 221
Wilmington 210
Nürnberg 207
Milan 203
Rome 202
Munich 194
Princeton 176
Warsaw 167
Dearborn 158
Moscow 158
Izmir 155
Chicago 147
Ho Chi Minh City 141
Marseille 137
São Paulo 137
Cattolica 136
Houston 132
Frankfurt am Main 123
The Dalles 123
Woodbridge 123
Hong Kong 115
Helsinki 113
Nanchang 108
Seattle 102
Hanoi 99
Boardman 89
Redwood City 84
Bremen 83
Fairfield 83
Kent 83
Buffalo 79
Tokyo 75
Brussels 70
Shenyang 67
Turku 67
Zhengzhou 67
Lancaster 63
Santa Clara 59
London 58
Seoul 58
Kunming 57
Lawrence 56
Hebei 53
Nuremberg 52
Rio de Janeiro 52
Denver 51
Hangzhou 50
Tianjin 50
Changsha 49
Brooklyn 48
Norwalk 48
Guangzhou 46
Hyderabad 45
Augusta 44
Toronto 42
University Park 42
Mountain View 40
Pune 40
Redmond 40
San Jose 40
Stockholm 39
Baghdad 38
Montreal 38
Vienna 38
Atlanta 37
Kraków 37
Phoenix 36
Poplar 36
Abidjan 35
Dhaka 35
Belo Horizonte 34
Amsterdam 32
Düsseldorf 31
Jiaxing 31
Jinan 31
Johannesburg 31
San Francisco 31
Chennai 30
Shanghai 30
Orem 29
Mexico City 28
Leawood 27
Paris 26
Porto Alegre 26
Bexley 25
Falkenstein 25
Totale 15.266
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 442
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 334
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. 285
A phase II study of sunitinib in advanced hepatocellular carcinoma 244
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 236
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 224
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 217
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 213
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 211
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 201
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 198
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 195
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 192
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 189
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 186
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 182
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 177
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 174
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 168
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 167
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 166
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 165
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 164
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 163
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 162
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 161
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 158
recurrent acute hepatitis associated with use of cetrizine 156
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 155
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 153
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study 149
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 149
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 148
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 147
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis 146
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 146
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 146
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 145
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 143
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 142
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 141
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 141
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 141
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 140
[The treatment of hepatocellular carcinoma: an update] 140
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 139
New signs and old applications of echo-color-Doppler should always be comapred to a gold-standard 138
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 138
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 138
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 137
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 137
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 137
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 136
Sarilumab use in severe SARS-CoV-2 pneumonia 136
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 136
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 134
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report 134
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 134
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 131
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 130
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 129
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 129
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 128
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 128
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 127
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 127
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 126
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 126
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 124
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 124
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 124
COVID-19-Related Social Isolation Predispose to Problematic Internet and Online Video Gaming Use in Italy 124
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 124
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 122
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 122
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 122
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 121
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 121
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends 120
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 120
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 119
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 119
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 119
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 118
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 117
HEPATOCATT STUDY GROUP. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. 117
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 117
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 117
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 116
[Liver transplantation] 115
Appearance of duodenal folds and untreated adult celiac disease 114
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 114
Factors associated with lifetime suicide attempts in bipolar disorder: results from an Italian nationwide study 114
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 113
Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) – Part II - Solid lesions 112
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 112
Totale 15.251
Categoria #
all - tutte 137.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021937 0 0 0 0 0 58 156 24 228 92 317 62
2021/20222.119 143 170 38 128 130 55 43 316 76 156 391 473
2022/20234.691 620 587 386 663 297 560 246 398 526 101 189 118
2023/20242.506 116 692 95 120 114 375 133 92 29 156 230 354
2024/20255.337 131 133 473 203 401 197 203 321 775 489 1.069 942
2025/20268.698 2.089 432 1.174 1.686 2.679 638 0 0 0 0 0 0
Totale 31.528